Related references
Note: Only part of the references are listed.American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
Does Clinical Remission Lead to Normalization of EQ-5D in Patients with Rheumatoid Arthritis and Is Selection of Remission Criteria Important?
Louise Linde et al.
JOURNAL OF RHEUMATOLOGY (2010)
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard
Alejandro Balsa et al.
RHEUMATOLOGY (2010)
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
J. S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Rheumatoid Arthritis Joint Progression in Sustained Remission Is Determined by Disease Activity Levels Preceding the Period of Radiographic Assessment
D. Aletaha et al.
ARTHRITIS AND RHEUMATISM (2009)
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
D. Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Reporting Disease Activity in Clinical Trials of Patients With Rheumatoid Arthritis: EULAR/ACR Collaborative Recommendations
D. Aletaha et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
The importance of reporting disease activity states in rheumatoid arthritis clinical trials
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
New therapies for treatment of rheumatoid arthritis
Josef S. Smolen et al.
LANCET (2007)
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
M. F. Bakker et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate -: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes
Robert Landewe et al.
ARTHRITIS AND RHEUMATISM (2006)
Measuring function in rheumatoid arthritis - Identifying reversible and irreversible components
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2006)
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2006)
The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey
D. Aletaha et al.
RHEUMATOLOGY (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Comparison of different definitions to classify remission and sustained remission:: 1 year TEMPO results
D van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
H Mäkinen et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states
D Aletaha et al.
ARTHRITIS AND RHEUMATISM (2005)
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement - A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2004)
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
JS Smolen et al.
RHEUMATOLOGY (2003)
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: Guidelines from a roundtable discussion
D van der Heijde et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
JM Bathon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
P Emery et al.
RHEUMATOLOGY (2000)
Share Paper
